|
TMEM161B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.089410E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.739400E-01 |
| Normal-vs-Stage2 |
7.533800E-01 |
| Normal-vs-Stage3 |
2.257600E-03 |
| Normal-vs-Stage4 |
5.6684000000029E-05 |
| Stage1-vs-Stage2 |
7.577800E-01 |
| Stage1-vs-Stage3 |
3.630100E-04 |
| Stage1-vs-Stage4 |
3.40369999995982E-06 |
| Stage2-vs-Stage3 |
1.516300E-02 |
| Stage2-vs-Stage4 |
2.601400E-03 |
| Stage3-vs-Stage4 |
3.330200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.242790E-01 |
| Normal-vs-AfricanAmerican |
1.566400E-01 |
| Normal-vs-Asian |
7.890800E-01 |
| Caucasian-vs-AfricanAmerican |
7.531600E-01 |
| Caucasian-vs-Asian |
8.296800E-01 |
| AfricanAmerican-vs-Asian |
6.771400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.586200E-02 |
| Normal-vs-Female |
3.477800E-01 |
| Male-vs-Female |
5.011600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.444420E-03 |
| Normal-vs-Age(41-60Yrs) |
1.281820E-01 |
| Normal-vs-Age(61-80Yrs) |
3.158200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.989400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.526390E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.220300E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.614200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.678800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.535600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.640600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.737000E-01 |
| Normal-vs-Grade 2 |
7.414800E-01 |
| Normal-vs-Grade 3 |
2.428000E-02 |
| Normal-vs-Grade 4 |
1.93340000009812E-07 |
| Grade 1-vs-Grade 2 |
9.231400E-01 |
| Grade 1-vs-Grade 3 |
3.286400E-01 |
| Grade 1-vs-Grade 4 |
3.881500E-03 |
| Grade 2-vs-Grade 3 |
5.761900E-03 |
| Grade 2-vs-Grade 4 |
7.3936999855917E-09 |
| Grade 3-vs-Grade 4 |
3.038000E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.082600E-01 |
| Normal-vs-ccB subtype |
6.175500E-02 |
| ccA subtype-vs-ccB subtype |
2.173600E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.712980E-01 |
| Normal-vs-N1 |
9.635700E-04 |
| N0-vs-N1 |
2.427700E-02 |
|
|
